Google has unveiled a smartwatch which only gives the wearer such old-fashioned data as time and data. However, beneath the surface the Verily device is busy collecting physiological information such as heart rates and electrocardiograms, while tracking movement data and measuring the likes of electrical conductance.
Verily can’t be bought in the open market, though. Google calls it its investigational ‘Study Watch’ and says it’s loaded with a mobile app so that wearers are able to provide ‘continuous insights’ throughout their everyday lives.
Verily is part of the company’s Project Baseline which aims to improve human health. The initiative boasts a broad group of participants that will comprise individuals who are exceptionally healthy, those at risk of disease, and those with overt problems. They will provide Baseline with deep data with repeat sampling over the course of four years.
This is no Google secret project. Verily teams are working closely with Duke University School of Medicine and Stanford Medicine, as well as with partners from academia, medicine, science, patient-advocacy, engineering and design. The plan is to make de-identified data from the Baseline study available to qualified researchers to spur new ideas across a wide ecosystem.